Arm CEO says AI could help cure cancer in our lifetime, but chip supply is a bottleneck

Arm CEO Rene Haas said AI could help cure cancer within our lifetime, especially speeding up drug discovery and testing. However, he warned chip supplies are tight, with AI demanding more computing power than ever. Building new fabs costs tens of billions and takes years, so the shortage may last. Experts note cancer is over 100 diseases, and individual differences make AI's clinical impact uncertain. Meanwhile, US data center growth raises community concerns about environment and resources.